Dudediligence.

NovoCure Limited

NVCRNASDAQ · Surgical & Medical Instruments & Apparatus
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$155.1MSep ’24$161.3MDec ’24$155.0MMar ’25$158.8MJun ’25$167.2MSep ’25$174.3MDec ’25$174.1MMar ’26$183.6MJun ’26
Net income, by quarter
−$30.6MSep ’24−$65.9MDec ’24−$34.3MMar ’25−$40.1MJun ’25−$37.3MSep ’25−$24.5MDec ’25−$71.1MMar ’26−$15.7MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$535.0M$537.8M$509.3M$605.2M$655.4M
Gross profit$420.2M$423.0M$381.1M$468.0M$488.5M
Operating income−$44.3M−$89.5M−$232.9M−$170.5M−$153.8M
Net income−$58.4M−$92.5M−$207.0M−$168.6M−$136.2M
Operating cash flow$82.8M$30.8M−$73.3M−$26.4M−$49.0M
Free cash flow$58.6M$9.4M−$100.4M−$69.2M−$75.7M
Cash$208.8M$115.3M$240.8M$163.8M$93.5M
Debt$562.2M$565.5M$568.8M$97.3M$195.0M
Shares outstanding104.0M105.0M107.1M108.5M112.5M